SEC Company Response from REGENTIS BIOMATERIALS LTD. (RGNT) (CIK 0001912966) (RGNT) — Sep 17, 2025
REGENTIS BIOMATERIALS LTD. (RGNT) (CIK 0001912966)
Date: Sept. 17, 2025 · CIK: 0001912966 · Accession: 0001213900-25-088587
AI Filing Summary & Sentiment
File numbers found in text: 333-285692
Show Raw Text
CORRESP
1
filename1.htm
September
17, 2025
VIA EDGAR
U.S. Securities
and Exchange Commission
Division of Corporation
Finance
100 F Street,
N.E.
Washington, DC
20549
RE:
Regentis Biomaterials Ltd. (CIK 0001912966)
Registration Statement No. 333-285692 on Form F-1
(the “Registration Statement”)
Ladies
and Gentlemen:
On
September 15, 2025, we, as the representative of the underwriters, filed a letter with the U.S. Securities and Exchange Commission via
EDGAR requesting, pursuant to Rule 461 under the Securities Act of 1933, as amended, the acceleration of the effective date of the above-referenced
Registration Statement so that it may be declared effective at 5:00 p.m., Eastern Time, on September 17, 2025, or as soon thereafter
as practicable. We are no longer requesting that such Registration Statement be declared effective at this specific date and time and
we hereby formally withdraw such request for acceleration.
Very
truly yours,
ThinkEquity
LLC
By:
/s/
Eric Lord
Eric
Lord
Head of Investment Banking